In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...